Objective: to develop a new liver-on-chip model that includes a relevant 3D matrix for hepatic cell growth and function with the use of of BIOMIMESYS® Liver hydroscaffold for a physiological 3D hepatocyte culture.
Ask for high quality link by putting your email below
View and download on Slideshare (low quality) https://www.slideshare.net/hcspharma/development-of-a-new-liveronchip-including-biomimesys-technology-for-mimicking-the-liver-extracellular-matrix-first-results-and-perspectives-165363388
Grégory MAUBON
Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs.
He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.
3 Comments
Artifical Intelligence and HCS in 3D cell culture: the perfect team to revolutionize drug discovery! | HCS Pharma · September 10, 2019 at 2:05 pm
[…] Organ-on-a-chip technology using BIOMIMESYS® […]
Kick-off meeting of ANR-funded project MIMLIVEROnChip | HCS Pharma · October 8, 2019 at 2:02 pm
[…] Don’t forget to take a look at our poster : “Development of a new liver-on-chip including BIOMIMESYS® technology for mimicking the liver extrace…“ […]
Feedback from Molecular Devices' User Meeting in Leiden | HCS Pharma · March 24, 2020 at 2:01 pm
[…] NO, BIOMIMESYS is not a hydrogel and YES, it can be cast in biochips! […]